发明授权
EP2475429B1 COMPOSITIONS COMPRISING ENZYME-CLEAVABLE KETONE-MODIFIED OPIOID PRODRUGS AND OPTIONAL INHIBITORS THEREOF
有权
组合物ENZYMSPALTBAREN酮改性阿片样物质药物和可选其抑制剂
- 专利标题: COMPOSITIONS COMPRISING ENZYME-CLEAVABLE KETONE-MODIFIED OPIOID PRODRUGS AND OPTIONAL INHIBITORS THEREOF
- 专利标题(中): 组合物ENZYMSPALTBAREN酮改性阿片样物质药物和可选其抑制剂
-
申请号: EP10815769.4申请日: 2010-04-21
-
公开(公告)号: EP2475429B1公开(公告)日: 2015-07-29
- 发明人: JENKINS, Thomas E. , HUSFELD, Craig O. , SEROOGY, Julie D. , WRAY, Jonathan W.
- 申请人: Signature Therapeutics, Inc.
- 申请人地址: 1731 Embarcadero Road, Suite 200 Palo Alto, CA 94303 US
- 专利权人: Signature Therapeutics, Inc.
- 当前专利权人: Signature Therapeutics, Inc.
- 当前专利权人地址: 1731 Embarcadero Road, Suite 200 Palo Alto, CA 94303 US
- 代理机构: Wytenburg, Wilhelmus Johannes
- 优先权: US240611P 20090908; US288148P 20091218
- 国际公布: WO2011031350 20110317
- 主分类号: C07D489/02
- IPC分类号: C07D489/02 ; C07D489/08 ; A61K31/485 ; A61P25/00
摘要:
A method of providing a patient with controlled release of ketone-containing opioid using a prodrug capable, upon enzymatic activation and intramolecular cyclization, of releasing the ketone-containing opioid is disclosed. The disclosure also provides such prodrug compounds and pharmaceutical compositions comprising such compounds. Such pharmaceutical compositions can optionally include an enzyme inhibitor that interacts with the enzyme(s) to mediate the enzymatically-controlled release of the ketone-containing opioid from the prodrug so as to modify enzymatic cleavage of the prodrug. Also included are methods to use such compounds and pharmaceutical compositions.
公开/授权文献
信息查询